Bio Protocol vs ssv.network — how do they compare? Bio Protocol trades at Rp440.73 (market cap Rp1,01T, Rp168,09M 24h volume), while ssv.network trades at Rp36,660 (market cap Rp579,62M, Rp90,14M 24h volume). The key difference: Bio Protocol is far larger — about 1742.5× ssv.network's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while ssv.network's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and ssv.network for 31 Days on average.
| BIO | SSV | |
|---|---|---|
Market Cap | Rp1,01T | Rp579,62M |
Volume (24h) | Rp168,09M | Rp90,14M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 15,8M SSV |
Typical Hold Time | 18 Days | 31 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →ssv.network is the first public implementation of the SSV primitive, which originated as a research piece by the Ethereum Foundation back in 2019 and since then has grown to a DAO governed, community driven network of stakers, builders and node operators. It functions as a distributed validator technology (DVT) project for Ethereum validators under development by Blox with grant funding distributed to supporting teams from the SSV DAO Treasury.
Read more on SSV →